How much bacteriostatic water with GHK-Cu?
Most research-handling protocols use 2 mL or 3 mL of bacteriostatic water per 50 mg GHK-Cu vial. Two millilitres yields a 25 mg/mL working concentration; three millilitres yields ~16.7 mg/mL. GHK-Cu dosing in preclinical research typically spans 1-2 mg per draw on a multi-week subcutaneous-administration schedule.
What the research literature says
GHK-Cu dosing across the published research literature typically uses per-draw amounts in the 1-2 mg range on a multi-week subcutaneous-administration schedule. The 50 mg vial size supports many draws at this dose tier — a typical protocol completes within or just past the 28-day post-reconstitution stability window.
For a 50 mg vial reconstituted with 2 mL of bacteriostatic water (25 mg/mL): a 1 mg dose draws 4 units on an insulin syringe; 2 mg draws 8 units. With 3 mL fill (~16.7 mg/mL): 1 mg = 6 units, 2 mg = 12 units. Both volumes keep per-draw syringe units in the easily-measurable range. Larger fills are sometimes used for protocols specifically requiring lower-concentration stocks.
The Pickart synthesis literature consolidates the broader GHK-Cu research framework across skin-regeneration (PMID 26236730), oxidative-stress (PMID 22666519), and gene-expression (PMID 29986520) contexts. The Kang keratinocyte work (PMID 19319546) provides the canonical mechanistic anchor for the dermal-research framing.
Why this matters in research context
GHK-Cu’s reconstitution math is simpler than the smaller-vial peptides because the larger 50 mg per-vial loading provides ample working stock for multi-week dose protocols at the typical sub-millilitre-per-draw range. The Cu(II) chromophore gives the reconstituted solution a characteristic blue colour — loss of the blue tint indicates dissociation of the copper-peptide complex and is the visual cue for stock-integrity monitoring.
Related compounds
- GHK-Cu 50mg — the compound covered by this answer
- Glow Blend — three-compound formulation including GHK-Cu
- KLOW Blend — four-compound formulation including GHK-Cu
Related research questions
References
- Kang YA et al. Copper-GHK increases integrin expression and p63 positivity by keratinocytes. Arch Dermatol Res 2009;301(4):301-306. [PMID 19319546]
- Pickart L et al. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev 2012;2012:324832. [PMID 22666519]
- Pickart L et al. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int 2015;2015:648108. [PMID 26236730]
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. GHK-Cu is sold strictly as a research-grade reagent for laboratory and bench research applications.